No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness

Anne B. Koopmans, David J. Vinkers, Igmar T. Poulina, Petra J. A. Gelan, Ron H. N. van Schaik, Hans W. Hoek, Peter N. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number349
Number of pages9
JournalFrontiers in Psychiatry
Volume9
DOIs
Publication statusPublished - 7 Aug 2018

Keywords

  • CYP2D6
  • severe mental illness (SMI)
  • guidelines
  • dose adjustment
  • genotyping
  • psychopharmacology
  • personalized medicine
  • CURACAO EXTRAPYRAMIDAL SYNDROMES
  • TARDIVE-DYSKINESIA
  • RATING-SCALE
  • PERSONALIZED MEDICINE
  • INDUCED AKATHISIA
  • SCHIZOPHRENIA
  • PHARMACOGENETICS
  • ANTIPSYCHOTICS
  • 2D6
  • POLYMORPHISMS

Cite this